ACHC

Healthcare

Acadia Healthcare Company, Inc. · Medical - Care Facilities · $2B

UQS Score — Balanced Preset
38.7
Average

Acadia Healthcare Company, Inc. scores 38.7/100 using the Balanced preset.

14.3
Quality
35%
28.0
Moat
30%
35.5
Growth
20%
55.7
Risk
15%

ACHC — Key Takeaways

✅ Strengths

Acadia Healthcare Company, Inc. shows attractive valuation relative to fundamentals

⚠️ Areas of Concern

Acadia Healthcare Company, Inc. has below-average profitability metrics
Acadia Healthcare Company, Inc. has limited competitive moat

ACHC — Score History

30354045Apr 2Apr 3Apr 4Apr 5Apr 6Apr 7Apr 8
DateUQSQualityMoatGrowthRiskValueChange
Apr 8, 202638.714.328.035.555.784.50.0
Apr 7, 202638.714.328.035.555.784.50.0
Apr 6, 202638.714.328.035.555.784.50.0
Apr 5, 202638.714.328.035.555.784.5-0.1
Apr 4, 202638.814.328.035.555.785.00.0
Apr 3, 202638.814.328.035.555.785.00.0
Apr 2, 202638.814.328.035.555.785.0

ACHC — Pillar Breakdown

Quality

14.3/100 (25%)

Acadia Healthcare Company, Inc. currently shows below-average quality metrics, suggesting challenges with profitability.

Capital Efficiency (ROIC)Weak

How effectively capital is deployed to generate returns.

Return on EquityWeak

Profitability relative to shareholders' equity.

Operating ProfitabilityWeak

Ability to convert revenue into operating profit.

Net ProfitabilityWeak

Bottom-line profit as a share of revenue.

Gross Profit / AssetsWeak

Asset productivity — how much gross profit each dollar of assets generates.

Cash GenerationWeak

Free cash flow relative to market value.

Growth

35.5/100 (20%)

Acadia Healthcare Company, Inc. shows steady but unspectacular growth, typical for mature companies.

Recent Revenue TrendWeak

Revenue trajectory over the last twelve months.

3Y Revenue CAGRWeak

Compound annual revenue growth rate over 3 years.

EPS GrowthWeak

Year-over-year earnings per share growth.

Forward Revenue OutlookWeak

Analyst consensus for future revenue growth.

Forward EPS GrowthStrong

Analyst consensus for future earnings growth.

Risk

55.7/100 (15%)

Acadia Healthcare Company, Inc. maintains a reasonable risk profile with manageable debt levels.

Financial LeverageStrong

Debt levels relative to earnings capacity.

Debt/EquityWeak

Total debt relative to shareholder equity.

Current RatioModerate

Short-term liquidity — ability to pay near-term obligations.

Interest CoverageWeak

Earnings capacity relative to interest payments.

Valuation

84.5/100 (15%)

Acadia Healthcare Company, Inc. appears attractively valued relative to its earnings, cash flows, and sector peers.

Earnings YieldStrong

Inverse of forward P/E — higher yield means cheaper stock.

PEG RatioStrong

P/E relative to earnings growth — lower is more attractive.

Moat

28/100 (30%)

Acadia Healthcare Company, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for ACHC.

Score Composition

Quality
14.3×25%3.6
Growth
35.5×20%7.1
Risk
55.7×15%8.4
Valuation
84.5×15%12.7
Moat
28.0×30%8.4
Total
38.7Average

Unlock Full ACHC Analysis

Sign in to access detailed financial metrics, interactive price charts, custom pillar weights, 6 investor presets, and watchlist tracking.

✓ Detailed ratios✓ Price chart✓ Custom moat ratings✓ 6 investor presets✓ Watchlist
Analyze ACHC in Detail →

More Stock Analysis

How is the ACHC UQS Score Calculated?

The UQS (Unified Quality Score) for Acadia Healthcare Company, Inc. is calculated using a proprietary 5-pillar framework with 25 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses Acadia Healthcare Company, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether Acadia Healthcare Company, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.